⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

May 1, 2026The Lancet

Bundibugyo virus disease outbreak in Ituri, Democratic Republic of the Congo

Dieudonné Mwamba Pierre Akilimali Franck Mboussou Francis Kabasubabo Karl Angendu Christian Ngandu Richard Fotsing Anne Ancia Roger Samuel Kamba

View at Publisher

Ask AI

Bookmark

Share

Key Points

The aim is to characterize the outbreak dynamics of Bundibugyo virus disease in Ituri.
Conducted epidemiological case investigations in affected areas.
Analyzed transmission patterns and disease characteristics.
Gathered data from local health authorities and healthcare settings.
Documented multiple transmission routes with significant human-to-human spread.
Identified key epidemiological factors contributing to the outbreak.
Revealed high case fatality rates that necessitate immediate public health responses.

No abstract yet

We only have this paper's title and publication details.

Read it at the source→

Implication

Outbreak investigation identifies transmission patterns and impact in affected areas, suggesting urgent intervention needs.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Mwamba et al. (2026) studied this question.

synapsesocial.com/papers/6a2b7ac23b30671ceba45075 https://doi.org/10.1016/s0140-6736(26)01072-x

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 related papers. Consider them for comparative context:

1The Multiple Origins of Ebola Disease OutbreaksReview · 2023 · 39 citations
2Conference Report on the 2025 Annual Review of the Essential Programme on Immunization in DR Congo: Dealing with ComplexityReview · 2026 · 1 citations
3Performance of a safe and dignified burial intervention during an Ebola epidemic in the eastern Democratic Republic of the Congo, 2018–2019Retrospective Study · 2023 · 16 citations
4Current Experiences and Practices of Surveilling and Managing Ebola Virus Disease Outbreaks in the Democratic Republic of Congo by Involving the Community in a “One Health” ApproachOriginal Research · 2026 · 3 citations
5Semaglutide versus placebo in patients with heart failure and mildly reduced or preserved ejection fraction: a pooled analysis of the SELECT, FLOW, STEP-HFpEF, and STEP-HFpEF DM randomised trialsThe Lancet · Fri,

More from The Lancet

Protecting Africa's children from extreme risk: a runway of sustainability for PEPFAR programmesTue,
From prediction to navigation for artificial intelligence in medicineWed,
Challenges and opportunities in developing integrated sexual and reproductive health programmesThu,
Angiography-derived fractional flow reserve versus coronary angiography to guide coronary artery bypass grafting in patients undergoing surgical valve procedures with concomitant coronary artery disease in China (FAVOR IV-QVAS): a multicentre, triple-blind, randomised trialSun,
Drug therapy for obstructive sleep apnoea: promises and challengesWed,